Intra‐articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial

References

• Lawrence R. C., Helmick C. G., Arnett F. C., Devo R. A., Felson D. T., Giannini E. H., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778–99
   PubMed Web of Science ®Google Scholar
• United States Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Aging. Center for Disease Control's role in combating the burden of arthritis. Department of Health and Human Services, Washington, DC 2004
   Google Scholar
• Leardini G., Salaffi F., Caporali R., Canesi B., Rovati L., Montanelli R., Italian Group for Study of the Costs of Arthritis. Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol 2004; 22: 699–706
   PubMed Web of Science ®Google Scholar
• Peat G., McCarney R., Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 2001; 60: 91–7
   PubMed Web of Science ®Google Scholar
• Jordan K. M., Arden N. K., Doherty M., Bannwarth B., Bijlsma J. W., Dieppe P., et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–55
   PubMed Web of Science ®Google Scholar
• Ettinger W. H Jr., Burns R., Messier S. P., Applegate W., Rejeski W. J., Morgan T., et al. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: the Fitness Arthritis and Seniors Trial (FAST). J Am Med Assoc 1997; 277: 25–31
   PubMed Web of Science ®Google Scholar
• Baker K. R., Nelson M. E., Felson D. T., Layne J. E., Samo R., Roubenoff R. The efficacy of home based progressive strength training in older adults with knee osteoarthritis: a randomized controlled trial. J Rheumatol 2001; 28: 1656–65
   Google Scholar
• Messier S. P., Loeser R. F., Miller G. D., Morgan T. M., Rejeski W. J., Seivick M. A., et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum 2004; 50: 1501–10
   PubMed Web of Science ®Google Scholar
• Knutson K., Lewold S., Robertsson O., Lidgren I. The Swedish knee arthroplasty register. A nation‐wide study of 30,003 knees 1976–1992. Acta Orthop Scand 1994; 65: 375–86
   PubMed Web of Science ®Google Scholar
• Kane R. L., Saleh K. J., Wilt T. J., Bershadsky B., Cross W. W., MacDonald R. M., et al. Total knee replacement. Agency for Healthcare Research and Quality, Rockville, MD 2003, Evidence report/technology assessment no. 86
   Google Scholar
• Murray D. W., Goodfellow J. W., O'Connor J. J. The Oxford medial unicompartmental arthroplasty: a ten‐year survival study. J Bone Joint Surg Br 1998; 80: 983–9
   PubMedGoogle Scholar
• Gabriel S. E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti‐inflammatory drugs: a meta‐analysis. Ann Intern Med 1991; 115: 787–96
   PubMed Web of Science ®Google Scholar
• Wolfe M. M., Lichtenstein D. R., Singh G. Gastrointestinal toxicity of nonsteroidal anti‐inflammatory drugs. N Engl J Med 1999; 340: 1888–9
   PubMed Web of Science ®Google Scholar
• Fitzgerald G. A. Coxibs and cardiovascular disease. N Engl J Med 2004; 351: 1709–11
   PubMed Web of Science ®Google Scholar
• Nussmeier N. A., Whelton A. A., Brown M. T., Langford R. M., Hoeft A., Parlow J. L., et al. Complications of the COX‐2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005; 352: 1081–91
   PubMed Web of Science ®Google Scholar
• Clegg D. O., Reda D. J., Harris C. L., Klein M. A., O'Dell J. R., Hooper M. M., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354: 795–808
   PubMed Web of Science ®Google Scholar
• Min B. H., Woo J. I., Cho H. S., Choi B. H., Park S. J., Choi M. J., et al. Effects of low‐intensity ultrasound (LIUS) stimulation on human cartilage explants. Scand J Rheumatol 2006; 35: 305–11
   PubMed Web of Science ®Google Scholar
• Vuolteenaho K., Kujala P., Moilanen T., Moilanen E. Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage. Scand J Rheumatol 2005; 34: 475–9
   PubMed Web of Science ®Google Scholar
• Lo G. H., LaValley M., McAlindon T., Felson D. T. Intra‐articular hyaluronic acid in treatment of knee osteoarthritis: a meta‐analysis. J Am Med Assoc 2003; 290: 3115–21
   PubMed Web of Science ®Google Scholar
• Arrich J., Piribauer F., Mad P., Schmid D., Klaushofer K., Mullner M. Intra‐articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta‐analysis. Can Med Assoc J 2005; 172: 1039–43
   PubMed Web of Science ®Google Scholar
• Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005; 2: CD005321
   Google Scholar
• Wang C. T., Lin J., Chang C. J., Lin Y. T., Hou S. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta‐analysis of randomized controlled trials. J Bone Joint Surg Am 2004; 86: 2567
   Google Scholar
• Lo G. H., LaValley M., McAlindon T., Felson D. T. Intra‐articular hyaluronic acid in treatment of knee osteoarthritis: a meta‐analysis. J Am Med Assoc 2003; 290: 3115–21
   PubMed Web of Science ®Google Scholar
• Maheu E., Ayral X., Dougados M. A hyaluronate preparation (500–730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 2002; 56: 804–13
   PubMed Web of Science ®Google Scholar
• Altman R., Moskowitz R. Hyaluronate sodium injections for osteoarthritis: the truth. Arch Intern Med 2002; 162: 245–7
   PubMedGoogle Scholar
• Dawes P. T., Kirlew C., Haslock I. Saline washout for knee osteoarthritis: results of a controlled study. Clin Rheumatol 1987; 6: 61–3
   PubMedGoogle Scholar
• Hubbard M. J. S. Articular debridement versus washout for degeneration of the medial femoral condyle. A five‐year study. J Bone Joint Surg 1996; 78: 217–19
   Google Scholar
• Egsmose C., Lund B., Andersen R. B. Hip joint distension in osteoarthritis. Scand J Rheumatol 1984; 13: 238–42
   PubMed Web of Science ®Google Scholar
• Bradley J. D., Heilman D. K., Katz B. D., Gsell P., Wallick J. E., Brandt K. D. Tidal irrigation as treatment for knee osteoarthritis. A sham‐controlled, randomized, double‐blinded evaluation. Arthritis Rheum 2002; 46: 100–8
   PubMedGoogle Scholar
• Kellgren J. H., Lawrence J. S. Radiological assessment of osteo‐arthrosis. Ann Rheum Dis 1957; 16: 494–502
   PubMed Web of Science ®Google Scholar
• Hochberg M. C., Chang R. W., Dwosh I., Lindsey S., Pincus T., Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498–502
   PubMed Web of Science ®Google Scholar
• Roos E. M., Roos H. P., Ekdahl C., Lohmander L. S. Knee injury and osteoarthritis outcome score (KOOS): validation of a Swedish version. Scand J Med Sci Sports 1998; 8: 439–48
   PubMed Web of Science ®Google Scholar
• Bellamy N., Watson Buchanan W., Goldsmith C. H., Campbell J., Stitt L. W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or the knee. J Rheumatol 1988; 15: 1833–40
   PubMed Web of Science ®Google Scholar
• Pham T., van der Heijde D., Altman R. D., Anderson J. J., Bellamy N., Hochberg M., et al. OMERACT‐OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004; 12: 389–99
   PubMed Web of Science ®Google Scholar
• Lohmander L. S., Dalen N., Englund G., Hämäläinen M., Jensen E. M., Karlsson K., et al. Intra‐articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized, double‐blind, placebo controlled multicentre trial. Ann Rheum Dis 1996; 55: 424–31
   PubMed Web of Science ®Google Scholar
• Peyron J. G., Altman R. D. The epidemiology of osteoarthritis. Osteoarthritis. Diagnosis and medical/surgical management, R. W Moskowitz, D. S Howell, V. M Goldberg, H. J Mankin. WB Saunders, Philadelphia 1992; 15–37, 2nd edn
   Google Scholar
• Bland J. H., Cooper S. M. Osteoarthritis. A review of the cell biology involved and evidence for reversibility. Semin Arthritis Rheum 1984; 14: 106–33
   PubMed Web of Science ®Google Scholar
• Brandt K. D., Smith G. N., Simon L. S. A review: intraarticular injection of hyaluronic acid as treatment for knee osteoarthritis. What is the evidence? Arthritis Rheum 2000; 43: 1192–203
   PubMed Web of Science ®Google Scholar
• Schulz K. F., Chalmers I., Hayes R. J., Altman D. G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Med Assoc 1995; 273: 408–12
   PubMed Web of Science ®Google Scholar
• Kjaergard L. L., Villumsen J., Gluud C. Reported methodological quality and discrepancies between large and small randomised trials in meta‐analyses. Ann Intern Med 2001; 135: 982–9
   PubMed Web of Science ®Google Scholar
• Als‐Nielsen B., Chen W., Gluud C., Kjaergard L. L. Association of funding and conclusions in randomised drug trials: a reflection of treatment effect or adverse events?. J Am Med Assoc 2003; 290: 921–8
   PubMed Web of Science ®Google Scholar
• Bekelman J. E., Li Y., Gross C. P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. J Am Med Assoc 2003; 289: 454–65
   PubMed Web of Science ®Google Scholar
• Lexchin J., Bero L. A., Djulbegovic B., Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Br Med J 2003; 326: 1167–70
   PubMed Web of Science ®Google Scholar
• House of Commons Health Committee. The influence of the pharmaceutical industry. Fourth report of session 2004–05. Vol. I, 2005. Available from: www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4202.htm
   Google Scholar
• Eichacker P. Q., Natanson C., Danner R. L. Surviving sepsis – practice guidelines, marketing campaigns, and Eli Lilly. New Engl J Med 2006; 355: 1640–2
   PubMed Web of Science ®Google Scholar
• Datamonitor Market Dynamics – hyaluronic acid viscosupplementation. . Reference code DMHC177, June 2002. Available from: www.datamonitor.com
   Google Scholar